epo hypertension

Erythropoietin-induced hypertension, also known as EPO hypertension, is a condition where blood pressure increases due to the administration of erythropoietin (EPO). Typically, this rise in blood pressure may be subtle, but if left unmanaged, it can escalate over time.

Patients undergoing EPO therapy may notice fluctuations in their blood pressure. At the outset, the increase might be subtle, potentially due to EPO's effect on the kidneys to produce more red blood cells, which can heighten blood viscosity and vascular resistance. Without vigilant blood pressure monitoring and management, the pressure can escalate, potentially leading to hypertension. Moreover, individual sensitivities to EPO can vary, with some patients at a higher risk for elevated blood pressure.

For patients receiving EPO treatment, regular blood pressure monitoring and adherence to medical guidance are essential. Should there be a persistent upward trend in blood pressure, immediate medical consultation is advised, and treatment adjustments should be made in accordance with the physician's recommendations. It is imperative not to alter medication dosages or discontinue treatment without professional guidance to prevent any detrimental impact on health.